News

Hosted on MSN3mon
Amgen got expanded FDA label approval for Uplizna - MSN
Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval for Uplizna, now approved as a treatment for immunoglobulin G4-related ...
Onlymyhealth on MSN2d
Decoding Food Labels: Expert Explains What Terms Like "Lab Tested", "FSSAI Approved", or "Safe to Eat" Actually Mean
Whenever we buy food, most of us don’t read the details beyond the price and the expiry date. However, this approach is ...
Seeking Alpha28d
FDA approves label updates for CAR-T cell therapies (update)
Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell therapies. Read more here.
Monthly Prescribing Reference28d
FDA Removes REMS, Reduces Monitoring Requirements For Breyanzi and ...
The Food and Drug Administration (FDA) has approved an updated label for both chimeric antigen receptor (CAR) T-cell therapies, Breyanzi ® (lisocabtagene maraleucel) and Abecma ® (idecabtagene ...
Seeking Alpha3mon
Amgen gets expanded FDA label approval for Uplizna
Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval for Uplizna, now approved as a treatment for immunoglobulin G4-related ...